Neurocast Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $49.1K

  • Investors
  • 3

Neurocast General Information

Description

Developer of a patient monitoring platform intended to better understand the course and cause of chronic disorders in clinical trials. The company's technology utilizes data science and machine learning algorithms to detect early warning signals in chronic neurological diseases from a user's typing behavior and sensor data on smartphones, enabling researchers to better diagnose neurological diseases and helping pharmaceutical companies run clinical trials more efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • De Entree 234
  • 4th Floor
  • 1101 EE Amsterdam
  • Netherlands
+31 085
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • De Entree 234
  • 4th Floor
  • 1101 EE Amsterdam
  • Netherlands
+31 085

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurocast Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 05-Nov-2022 $49.1K Completed Generating Revenue
2. Early Stage VC 18-Dec-2020 Completed Generating Revenue
1. Early Stage VC 01-Aug-2018 $1.2M $1.2M Completed Generating Revenue
To view Neurocast’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Neurocast Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurocast Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Health Accelerator/Incubator
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority
Axivate Capital Growth/Expansion Minority
To view Neurocast’s complete investors history, request access »

Neurocast FAQs

  • When was Neurocast founded?

    Neurocast was founded in 2017.

  • Where is Neurocast headquartered?

    Neurocast is headquartered in Amsterdam, Netherlands.

  • What is the size of Neurocast?

    Neurocast has 14 total employees.

  • What industry is Neurocast in?

    Neurocast’s primary industry is Decision/Risk Analysis.

  • Is Neurocast a private or public company?

    Neurocast is a Private company.

  • What is Neurocast’s current revenue?

    The current revenue for Neurocast is .

  • How much funding has Neurocast raised over time?

    Neurocast has raised $2.75M.

  • Who are Neurocast’s investors?

    EIT Health, Johnson & Johnson Innovation - JLABS, and Axivate Capital have invested in Neurocast.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process